LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells
Abstract Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor and an oncogene product, which plays a pivotal role in tumor progression. Therefore, targeting persistent STAT3 signaling directly is an attractive anticancer strategy. The aim of this study is to test the...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/bfd18968512a4e99a84e2b1b85bb2f69 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:bfd18968512a4e99a84e2b1b85bb2f69 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:bfd18968512a4e99a84e2b1b85bb2f692021-12-02T13:24:26ZLLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells10.1038/s41598-021-85888-x2045-2322https://doaj.org/article/bfd18968512a4e99a84e2b1b85bb2f692021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85888-xhttps://doaj.org/toc/2045-2322Abstract Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor and an oncogene product, which plays a pivotal role in tumor progression. Therefore, targeting persistent STAT3 signaling directly is an attractive anticancer strategy. The aim of this study is to test the efficacy of a novel STAT3 small molecule inhibitor, LLL12B, in suppressing medulloblastoma cells in vitro and tumor growth in vivo. LLL12B selectively inhibited the induction of STAT3 phosphorylation by interleukin-6 but not induction of STAT1 phosphorylation by INF-γ. LLL12B also induced apoptosis in human medulloblastoma cells. In addition, LLL12B exhibited good oral bioavailability in vivo and potent suppressive activity in tumor growth of medulloblastoma cells in vivo. Besides, combining LLL12B with cisplatin showed greater inhibition of cell viability and tumorsphere formation as well as induction of apoptosis comparing to single agent treatment in medulloblastoma cells. Furthermore, LLL12B and cisplatin combination exhibited greater suppression of medulloblastoma tumor growth than monotherapy in vivo. The present study supported that LLL12B is a novel therapeutic agent for medulloblastoma and the combination of LLL12B with a chemotherapeutic agent cisplatin may be an effective approach for medulloblastoma therapy.Xiang ChenLi PanJia WeiRuijie ZhangXiaozhi YangJinhua SongRen-Yuan BaiShengling FuChristopher R. PiersonJonathan L. FinlayChenglong LiJiayuh LinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Xiang Chen Li Pan Jia Wei Ruijie Zhang Xiaozhi Yang Jinhua Song Ren-Yuan Bai Shengling Fu Christopher R. Pierson Jonathan L. Finlay Chenglong Li Jiayuh Lin LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| description |
Abstract Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor and an oncogene product, which plays a pivotal role in tumor progression. Therefore, targeting persistent STAT3 signaling directly is an attractive anticancer strategy. The aim of this study is to test the efficacy of a novel STAT3 small molecule inhibitor, LLL12B, in suppressing medulloblastoma cells in vitro and tumor growth in vivo. LLL12B selectively inhibited the induction of STAT3 phosphorylation by interleukin-6 but not induction of STAT1 phosphorylation by INF-γ. LLL12B also induced apoptosis in human medulloblastoma cells. In addition, LLL12B exhibited good oral bioavailability in vivo and potent suppressive activity in tumor growth of medulloblastoma cells in vivo. Besides, combining LLL12B with cisplatin showed greater inhibition of cell viability and tumorsphere formation as well as induction of apoptosis comparing to single agent treatment in medulloblastoma cells. Furthermore, LLL12B and cisplatin combination exhibited greater suppression of medulloblastoma tumor growth than monotherapy in vivo. The present study supported that LLL12B is a novel therapeutic agent for medulloblastoma and the combination of LLL12B with a chemotherapeutic agent cisplatin may be an effective approach for medulloblastoma therapy. |
| format |
article |
| author |
Xiang Chen Li Pan Jia Wei Ruijie Zhang Xiaozhi Yang Jinhua Song Ren-Yuan Bai Shengling Fu Christopher R. Pierson Jonathan L. Finlay Chenglong Li Jiayuh Lin |
| author_facet |
Xiang Chen Li Pan Jia Wei Ruijie Zhang Xiaozhi Yang Jinhua Song Ren-Yuan Bai Shengling Fu Christopher R. Pierson Jonathan L. Finlay Chenglong Li Jiayuh Lin |
| author_sort |
Xiang Chen |
| title |
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| title_short |
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| title_full |
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| title_fullStr |
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| title_full_unstemmed |
LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| title_sort |
lll12b, a small molecule stat3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/bfd18968512a4e99a84e2b1b85bb2f69 |
| work_keys_str_mv |
AT xiangchen lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT lipan lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT jiawei lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT ruijiezhang lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT xiaozhiyang lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT jinhuasong lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT renyuanbai lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT shenglingfu lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT christopherrpierson lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT jonathanlfinlay lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT chenglongli lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells AT jiayuhlin lll12basmallmoleculestat3inhibitorinducesgrowtharrestapoptosisandenhancescisplatinmediatedcytotoxicityinmedulloblastomacells |
| _version_ |
1718393118317871104 |